Caitlin Raymond: Framing Donor Eligibility as Risk Assessment
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
“Donor infectious disease eligibility sounds straightforward — until it isn’t. I just published a new post for trainees framing donor eligibility as risk assessment, not a checklist — the way boards expect you to understand it and the way it actually works in practice. In this post I cover:
- Why some pathogens get NAT, others don’t.
- Why some are tested once, others every donation.
- Why donor history still matters in the era of ultra-sensitive testing.
If you work in transfusion medicine, blood banking, pathology, or are studying for boards, this one’s meant to connect the dots between regulations, biology, and real-world decisions.”
Title: Board Prep: Overview of Donor Infectious Disease Eligibility
Author: Caitlin Raymond
Read the full article here.
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management
-
Sep 23, 2026, 06:06Advancing Hemophilia Care and Patient Advocacy in Bangladesh – World Federation of Hemophilia
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility